1. Home
  2. DRMA vs ITOC Comparison

DRMA vs ITOC Comparison

Compare DRMA & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$1.26

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

ITOC

iTonic Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$0.31

Market Cap

5.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DRMA
ITOC
Founded
2014
1998
Country
United States
China
Employees
9
7
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DRMA
ITOC
Price
$1.26
$0.31
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
53.0K
1.9M
Earning Date
05-14-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$650.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.25
52 Week High
$7.33
$1.15

Technical Indicators

Market Signals
Indicator
DRMA
ITOC
Relative Strength Index (RSI) 51.29 46.93
Support Level $1.13 $0.29
Resistance Level $1.40 $0.41
Average True Range (ATR) 0.09 0.12
MACD 0.00 -0.00
Stochastic Oscillator 39.95 4.08

Price Performance

Historical Comparison
DRMA
ITOC

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

About ITOC iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.

Share on Social Networks: